Lombard Odier Asset Management USA Corp purchased a new position in shares of UnitedHealth Group (NYSE:UNH) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 16,262 shares of the healthcare conglomerate’s stock, valued at approximately $3,585,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Exane Derivatives boosted its stake in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after purchasing an additional 460 shares during the period. Aevitas Wealth Management Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth about $102,000. Pathstone Family Office LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at about $129,000. Trustcore Financial Services LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at about $133,000. Finally, Intellectus Partners LLC lifted its holdings in UnitedHealth Group by 18.2% during the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after buying an additional 126 shares in the last quarter. 86.78% of the stock is owned by hedge funds and other institutional investors.
NYSE:UNH opened at $230.32 on Tuesday. UnitedHealth Group has a one year low of $164.96 and a one year high of $250.79. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $217,027.44, a PE ratio of 22.87, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same quarter in the previous year, the business posted $2.11 EPS. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. research analysts forecast that UnitedHealth Group will post 12.52 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were issued a $0.75 dividend. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.30%. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total value of $2,463,800.00. Following the transaction, the director now owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the transaction, the director now directly owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. In the last 90 days, insiders sold 77,015 shares of company stock valued at $17,879,199. Company insiders own 0.89% of the company’s stock.
A number of equities research analysts recently weighed in on UNH shares. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a report on Monday, December 25th. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Goldman Sachs started coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price objective for the company. Evercore ISI reiterated an “outperform” rating and set a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Finally, Piper Jaffray reiterated a “buy” rating and set a $259.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Three investment analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $244.62.
COPYRIGHT VIOLATION NOTICE: “Lombard Odier Asset Management USA Corp Purchases New Position in UnitedHealth Group (UNH)” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/17/lombard-odier-asset-management-usa-corp-purchases-new-position-in-unitedhealth-group-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.